INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Regenerative medicine laws and requirements in Texas. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Unapproved Cell Therapies | permit cell therapies | Tex. Health & Safety Code §§ 1003.051-1003.060 (ch. 1003, subch. B)““Investigational stem cell treatment” means an adult stem cell treatment that: (A) is under investigation in a clinical trial and being administered to human participants in that trial; and (B) has not yet been approved for general use by the United States Food and Drug Administration.” | Link | 2026-10-09 | high |
| Require Patient Disclosure for Cell Therapies | require disclosure | Tex. Health & Safety Code § 1003.054“(a) Before receiving an investigational stem cell treatment, an eligible patient must sign a written informed consent.” | Link | 2026-10-09 | high |
| Limit Practitioner Scope for Cell Therapies | MD/DO; IRB oversight | Tex. Health & Safety Code § 1003.055“Treatment provided under this subchapter must be: (1) administered directly by a physician certified under Subsection (c); (2) overseen by an institutional review board described by Subsection (d);” | Link | 2026-10-09 | high |
| Have Cell Therapy Statute References | Tex. Health & Safety Code §§ 1003.051-1003.060 (HB 810, 2017; amended HB 3148, 2019) | Tex. Health & Safety Code § 1003.051“Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.”Note: Stored § 1003.001 is 'Establishment of Adult Stem Cell Bank', not the investigational stem cell treatment provisions (subchapter B, §§ 1003.051-.060). HB 3148 (2019) amendments are shown in the history of §§ 1003.054-.055. | Link | 2026-10-09 | high |
View full Texas profile (all layers) · Report an error on this page